KUKJE PHARMA Co., Ltd.
KUKJE PHARMA Co., Ltd. (KRX: 002720) is trading at ₩4,270.00, about ₹308 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 3.61% today. KUKJE PHARMA is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩4,160.00
Today's high
₩4,855.00
52 week low
₩2,810.00
52 week high
₩5,470.00
002720 opened at ₩4,650.00, closed previously at ₩4,430.00, and has traded between ₩2,810.00 and ₩5,470.00 over the past 52 weeks.
About
KUKJE PHARMA Co. Ltd. engages in the manufacture, sale, and distribution of pharmaceutical, cosmetics, and healthcare products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antibiotics, and antifungal and antiviral agents. The company was founded on July 27, 1959 and is headquartered in Seongnam, South Korea.
Key statistics
Avg. volume
68.64K
Market cap
₩90.35B
P/E Ratio
17.80
Price-to-sales ratio
0.50
Enterprise value
₩107.35B
Free cash flow yield
2.53%
Debt-to-equity ratio
0.32
Return on equity
5.83%
ROIC
3.45%
Beta
0.27
Dividend yield
0.70%
Last dividend
₩30.00
Financial overview
Revenue
₩175.50B
Earnings per share
₩279.51
Free cash flow
₩2.22B
Net profit margin
2.76%
Gross margin
53.46%
EBITDA
₩9.41B
Revenue growth
12.16%
Similar securities
This is not an investment recommendation
KUKJE PHARMA for Indian investors
KUKJE PHARMA is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on KUKJE PHARMA for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. KUKJE PHARMA’s current yield is 0.70%.Dividend tax explained
FAQs
Can I buy KUKJE PHARMA on Paasa?
KUKJE PHARMA (002720) has been listed on the Korea Exchange since 2005, in the Medical - Pharmaceuticals industry. KUKJE PHARMA is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one KUKJE PHARMA share cost in rupees?
One KUKJE PHARMA share is ₩4,270.00 — about ₹308 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the KUKJE PHARMA price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on KUKJE PHARMA shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the KUKJE PHARMA price.
Does KUKJE PHARMA pay a dividend, and how is it taxed in India?
Yes. KUKJE PHARMA pays a dividend and the current yield is 0.70%; the last declared dividend was ₩30.00 per share, about ₹2.17. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare KUKJE PHARMA shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on KUKJE PHARMA?
Yes. KUKJE PHARMA is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.